GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Intuitive Surgical, Inc. (ISRG) [hlAlert]

Rating:
Overweight
ISRG
up 0.97 %

Intuitive Surgical, Inc. (ISRG) upgraded to Overweight by JP Morgan

Posted on: Monday,  Oct 15, 2012  8:25 AM ET by JP Morgan

JP Morgan rated Overweight Intuitive Surgical, Inc. (NASDAQ: ISRG) on 10/15/2012, when the stock price was $510.57. Since
then, Intuitive Surgical, Inc. has gained 0.98% as of 01/22/2016's recent price of $515.57.
If you would have followed this JP Morgan's recommendation on ISRG, you would have gained 0.97% of your investment in 1194 days.

Intuitive Surgical, Inc. designs and manufactures the da Vinci Surgical System. The da Vinci Surgical System seamlessly translates the surgeon's natural hand movements on instrument controls at a console into corresponding micromovements of instruments positioned inside the patient through small puncture incisions, or ports. The products provide the surgeon with the range of motion and fine tissue control previously possible only with open surgery, while simultaneously allowing the surgeon to work through small ports.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/15/2012 8:25 AM Buy
None
510.57
as of 12/31/2012
1 Week up  0.13 %
1 Month down  -7.30 %
3 Months down  -3.95 %
1 YTD down  -3.95 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2008 8:25 AM Hold
None
133.30 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy